跳至主要内容
临床试验/JPRN-C000000387
JPRN-C000000387已完成未知

An open label randomized controlled trial on the preemptive risedronate intervention for glucocorticoid-induced osteoporosis in chronic kidney disease patients - The Preemptive Risedronate Intervention for those Undergoing Steroid therapy with Chronic Kidney Diseases (PRIUS-CKD Study )

Department of Nephrology, Osaka University School of Medicine0 个研究点目标入组 100 人开始时间: 2006年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients receiving specific treatments that affect bone and mineral metabolism such as SERM, HRT, calcitonin, recombinant human PTH, and other bisphosphonate, except for active vitamin D. Patients in or expecting pregnancy

研究者

发起方
Department of Nephrology, Osaka University School of Medicine

相似试验